Financial reports
Current reports
8-K
Departure of Directors or Certain Officers
22 Apr 24
8-K
Termination of a Material Definitive Agreement
12 Mar 24
8-K
Other Events
27 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Feb 24
8-K
Entry into a Material Definitive Agreement
18 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Sep 23
8-K
Lucy Scientific Discovery Inc. Announces Acquisition of BlueSky Wellness Inc. in All-Stock Transaction
12 Sep 23
8-K
Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction
8 Sep 23
8-K
Departure of Directors or Certain Officers
28 Jul 23
8-K
Lucy Scientific Discovery, Inc. Achieves Major Milestone with Successful Completion of its Acquisition of the Assets of Wesana Health
7 Jul 23
Registration and prospectus
424B3
Prospectus supplement
1 Mar 24
S-1/A
IPO registration (amended)
22 Feb 24
S-1/A
IPO registration (amended)
5 Feb 24
S-1
IPO registration
12 Jan 24
425
Business combination disclosure
8 Sep 23
425
Business combination disclosure
6 Jun 23
424B4
Prospectus supplement with pricing info
10 Feb 23
8-A12B
Registration of securities on exchange
8 Feb 23
FWP
Free writing prospectus
6 Feb 23
S-1/A
IPO registration (amended)
6 Feb 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
28 Feb 24
CERT
Certification of approval for exchange listing
9 Feb 23
EFFECT
Notice of effectiveness
9 Feb 23
CORRESP
Correspondence with SEC
6 Feb 23
CORRESP
Correspondence with SEC
6 Feb 23
CORRESP
Correspondence with SEC
6 Feb 23
CORRESP
Correspondence with SEC
6 Feb 23
CORRESP
Correspondence with SEC
6 Feb 23
CORRESP
Correspondence with SEC
2 Feb 23
CORRESP
Correspondence with SEC
31 Jan 23